These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 27955666

  • 41. Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland.
    Ingimarsson O, MacCabe JH, Sigurdsson E.
    Nord J Psychiatry; 2018 Oct; 72(7):497-500. PubMed ID: 30348045
    [Abstract] [Full Text] [Related]

  • 42. Does eosinophilia predict clozapine induced neutropenia?
    Hummer M, Sperner-Unterweger B, Kemmler G, Falk M, Kurz M, Oberbauer H, Fleischhacker WW.
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):201-4. PubMed ID: 8935817
    [Abstract] [Full Text] [Related]

  • 43. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report.
    Crépeau-Gendron G, L'Heureux S.
    Early Interv Psychiatry; 2015 Apr; 9(2):151-5. PubMed ID: 24690066
    [Abstract] [Full Text] [Related]

  • 44. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
    Coşar B, Taner ME, Eser HY, Altınöz AE, Tarhan R.
    J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
    [Abstract] [Full Text] [Related]

  • 45. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
    Pantelis C, Adesanya A.
    Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
    [No Abstract] [Full Text] [Related]

  • 46. Clozapine: the commitment to patient safety.
    Alphs LD, Anand R.
    J Clin Psychiatry; 1999 Aug; 60 Suppl 12():39-42. PubMed ID: 10372610
    [Abstract] [Full Text] [Related]

  • 47. Clozapine therapy during cancer treatment.
    Rosenstock J.
    Am J Psychiatry; 2004 Jan; 161(1):175. PubMed ID: 14702271
    [No Abstract] [Full Text] [Related]

  • 48. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
    Raveendranathan D, Sharma E, Venkatasubramanian G, Rao MG, Varambally S, Gangadhar BN.
    Gen Hosp Psychiatry; 2013 Jan; 35(5):574.e5-6. PubMed ID: 22902258
    [Abstract] [Full Text] [Related]

  • 49. Clozapine treatment in Australia: a review of haematological monitoring.
    Copolov DL, Bell WR, Benson WJ, Keks NA, Strazzeri DC, Johnson GF.
    Med J Aust; 1998 May 18; 168(10):495-7. PubMed ID: 9631674
    [Abstract] [Full Text] [Related]

  • 50. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.
    Lee J, Takeuchi H, Fervaha G, Powell V, Bhaloo A, Bies R, Remington G.
    J Clin Psychopharmacol; 2015 Oct 18; 35(5):510-6. PubMed ID: 26267420
    [Abstract] [Full Text] [Related]

  • 51. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A, Landry P, Deschamps R, Lessard M.
    Encephale; 2002 Oct 18; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [Abstract] [Full Text] [Related]

  • 52. Time for a change to clozapine haematological monitoring.
    Cheng A, Buten S, Large M.
    Australas Psychiatry; 2024 Aug 18; 32(4):342-345. PubMed ID: 38820548
    [Abstract] [Full Text] [Related]

  • 53. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
    Hollingworth SA, Winckel K, Saiepour N, Wheeler AJ, Myles N, Siskind D.
    Psychopharmacology (Berl); 2018 Jul 18; 235(7):1915-1921. PubMed ID: 29589067
    [Abstract] [Full Text] [Related]

  • 54. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov 18; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 55. Meta-analysis examining the epidemiology of clozapine-associated neutropenia.
    Myles N, Myles H, Xia S, Large M, Kisely S, Galletly C, Bird R, Siskind D.
    Acta Psychiatr Scand; 2018 Aug 18; 138(2):101-109. PubMed ID: 29786829
    [Abstract] [Full Text] [Related]

  • 56. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, Gochman P, Rapoport JL.
    J Child Adolesc Psychopharmacol; 2003 Aug 18; 13(3):401-4. PubMed ID: 14642024
    [Abstract] [Full Text] [Related]

  • 57. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J, Berdichevsky E, Conte G, Tellez C.
    Rev Med Chil; 1994 Jun 18; 122(6):694-8. PubMed ID: 7732216
    [Abstract] [Full Text] [Related]

  • 58. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.
    Gee S, Taylor D.
    J Psychiatry Neurosci; 2021 Mar 11; 46(2):E232-E237. PubMed ID: 33703870
    [Abstract] [Full Text] [Related]

  • 59. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A, Cosar B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul 11; 30(5):958-9. PubMed ID: 16631295
    [Abstract] [Full Text] [Related]

  • 60. Hematological and cardiometabolic safety of clozapine in the treatment of very early onset schizophrenia: a retrospective chart review.
    Midbari Y, Ebert T, Kosov I, Kotler M, Weizman A, Ram A.
    J Child Adolesc Psychopharmacol; 2013 Oct 11; 23(8):516-21. PubMed ID: 24111981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.